PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Clinical trial NCT01723774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01723774
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-10
- Primary completion
- 2021-04-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.